H. Magnussen (Grosshansdorf, Germany), A. Ten Brinke (Leeuwarden, Netherlands)
Symptom/risk assessment in alpha-1-antitrypsin deficiency (AATD) using the 2011 GOLD algorithm
A. Pillai, D. Griffiths, R. Edgar, R. Stockley (Birmingham, United Kingdom)
|   |
Reproducibility of non-invasive measures of arterial stiffness in mild to severe stable COPD using a new cuff-based operator independent device
I.S. Stone, S.E. Petersen, N.C. Barnes (London, United Kingdom)
| |
An analysis of patient acceptability of receiving a 72 hour phone call post discharge following a COPD exacerbation
V. Beasley, D. Macfie, M. Oyston, C. Otieno, S. Elkin (London, United Kingdom)
| |
Nighttime symptoms and reduced quality of life among COPD patients
M. Mocarski, C. Caracta, S. Tourkodimitris, E. Garcia Gil, J. Setyawan (Jersey City, United States Of America; Barcelona, Spain)
| |
The journey to severe obstructive lung disease – Retrospective study of FEV1 decline
R. Jones, M. Masoli, A. Qureshi, H. Grover, G. Hayes, F. Ali, D. Jones (Plymouth, United Kingdom)
| |
Comparison of quality of life scores with modified Medical Research Council (mMRC) dyspnoea scale using data from the European health-related quality of life study
P. Jones, L. Adamek, G. Nadeau, N. Banik (London, Uxbridge, United Kingdom; Munich, Germany)
| |
The effect of reducing breath holding time to assess diffusion capacity
E. Magro, B. Kenedy, S. Crinion, O. Cotter, D. Curran, T. O‘Connor (Cork, Ireland)
| |
Reference values for respiratory system resistance in adults
D. Burggraf, M. Heiß-Neumann, M. Wjst, L. Ziegler-Heitbrock, EvA Consortium (Gauting, Neuherberg, Germany)
| |
The longitudinal determinants of decline in COPD and asthma-COPD overlap in an Australian population
V. McDonald, J. Fu, J. Simpson, P. Gibson (Newcastle, Glebe, Australia)
| |
Association between COPD and other co-morbid conditions: Results from a 1-day, point-prevalence study in 2,04,912 patients from 860 cities and towns in India
S. Madas, K. Apte, M. Barne, S. Harangule, J. Gogtay, S. Chhowala, N. Mahajan, S. Sundeep (Pune, Mumbai, India)
| |
Anaemia and survival in COPD patients with acute hypercapnic respiratory failure
G. Probert, H.H. Mydin, S. Murphy (Sunderland, United Kingdom)
| |
Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease
M. Kardara, E. Dima, H. Giannakopoulou, S. Vakali, C. Roussos, N. Koulouris, N. Rovina (Athens, Greece)
| |
Peripheral neutrophil stiffness is increased in COPD severe exacerbations
E. Arismendi, T. Luque, Y. Torralba, A. Agusti, D. Navajas, R. Rodriguez-Roisin (Barcelona, Palma de Mallorca, Spain)
| |
Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry
A. Kronseder, M. Truger, S. Peters, S. Karrasch, A.R. Koczulla, D. Nowak, R.A. Jörres (Munich, Germany)
| |
Sputum VEGF level increases with treatment of COPD acute exacerbation
Z. Lázár, A. Bikov, G. Gálffy, G. Losonczy, I. Horváth (Budapest, Hungary)
| |
Interaction of relevant domains in the heterogeneity of severe COPD exacerbations: The exacerbome network
B.G. Cosio, D. Guerrero, R. Cordova, G. Peces-Barba, C. Esteban, A. de Diego, J. Gea, M. Garcia-Nuñez, E. Monsó, A. Agusti (Palma de Mallorca, Bunyola, Madrid, Galdacano, Valencia, Barcelona, Badalona, Sabadell, Spain)
| |
Association of gastro-esophageal reflux disease symptoms with COPD severity and acute exacerbations of COPD
K. Bartziokas, A. Papaioannou, S. Tsikrika, F. Karakontaki, Z. Nouvaki, A. Papadopoulos, E. Kastanakis, N. Karagiannidis, S. Loukides, S. Papiris, A. Haniotou, K. Kostikas (Athens, Greece)
| |
Antibiotic use for hospitalized chronic obstructive pulmonary disease exacerbations: A propensity adjusted analysis
A. Singanayagam, P. Short, R. Archibald, T. Fardon, M. Al-Khairalla, L. Peet, J. Taylor, D. Mills, S. Higgins, A. Akram, S. Schembri, J. Chalmers, P. Williamson (London, , Doncaster, Dundee, Perth, Livingston, United Kingdom)
| |